Related Experiment Videos
[Influence of topically applied iodides on urinary iodine excretion and thyroid function]
Andrzej Stankiewicz1, Maksymilian Siekierzyński, Joanna Wierzbowska
1Kliniki Okulistycznej Wojskowego Instytutu Medycznego w Warszawie.
Klinika Oczna
|October 14, 2003
Summary
Topical ophthalmic iodine drugs significantly increase urine iodine excretion but do not affect thyroid function (TSH, FT3, FT4) in patients without prior thyroid disease.
Area of Science:
- Ophthalmology
- Endocrinology
- Pharmacology
Background:
- Topical ophthalmic medications containing iodine are used for various eye conditions.
- The potential for systemic absorption and subsequent effects on thyroid function is a clinical concern.
Purpose of the Study:
- To evaluate the impact of an iodine-containing ophthalmic drug on urinary iodine excretion.
- To assess potential biochemical changes in thyroid function following topical ocular administration of iodine.
Main Methods:
- Twenty-two patients without a history of thyroid disease received Vitreolent (iodine-containing ophthalmic solution) four times daily for one month.
- Urinary iodine excretion was measured using the "Rapid Urinary Iodine Test".
- Thyroid function parameters, including TSH, FT3, and FT4, were assessed before and after treatment.
Main Results:
- A statistically significant increase in urinary iodine excretion was observed post-therapy.
- No significant changes were detected in TSH, FT3, or FT4 levels, indicating stable thyroid function.
Conclusions:
- Topical application of iodine-containing ophthalmic drugs leads to increased iodine excretion in urine.
- This regimen does not appear to induce biochemically relevant changes in thyroid function in euthyroid individuals.